Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
ESH CML 2022
🎥 @MdSwoboda of @TGHCares discusses the growing use of artificial intelligence in MDS, highlighting ongoing research in this area:
👉 👈
#MDSsm #ArtificialIntelligence #AIinHealthcare #HemOnc #SOHO2025
The growing role of AI in MDS: digital twins, machine learning tools, and more
David Swoboda, MD, Tampa General Hospital Cancer Center, Tampa, FL, discusses the growing use of artificial intelligen...
ow.ly
#iwHRMM25 | Sham Mailankody of @MSKCancerCenter discusses innovative approaches to trial design in high-risk #myeloma, highlighting how these may improve data collection:
🎥
#Myeloma #MMSM #HemOnc #CTSM
Innovative approaches to trial design in high-risk myeloma & how these may improve data collection
Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the challenges of treating high...
ow.ly
🎥 @DrAEvens of @RutgersCancer shares insights into the HoLISTIC Consortium, a global NIH-funded initiative that has aggregated data from over 30,000 patients with #HodgkinLymphoma.
Learn more by clicking here:
👉 👈
#18ICML #LYMsm #Lymphoma #HemOnc
Insights into the HoLISTIC Consortium & the value of this initiative
Andrew Evens, DO, MBA, FACP, Rutgers University, New Brunswick, NJ, shares insights into the HoLISTIC Consortium, a ...
ow.ly
It was a pleasure to speak with the lovely @helgasimonm of @amsterdamumc at #iwCLL2025 to hear about her work investigating the metabolic fitness of T-cells in patients with CLL.🩸🔬
Click here to learn more:
👉 👈
#CLLsm #Leusm #Leukemia #ImmunoOnc…
Investigating the metabolic fitness of T-cells in patients with CLL
In this video, Helga Simon-Molas, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, discusses her work i...
ow.ly
We recently spoke with @aaronchengmd (@PennMedicine), who shared insights from an analysis of morbidity rates in adults with non-transfusion-dependent #thalassemia referred to three US specialty centers.
Watch the interview here:
👉 👈
#Hematology
Examining the morbidity rate in adults with NTDT referred to US specialty centers
Aaron Cheng, MD, University of Pennsylvania, Philadelphia, PA, discusses the high morbidity rate in adults with non-tr...
ow.ly
ESH CML 2022
🎥 @MdSwoboda of @TGHCares discusses the growing use of artificial intelligence in MDS, highlighting ongoing research in this area:
👉 👈
#MDSsm #ArtificialIntelligence #AIinHealthcare #HemOnc #SOHO2025
The growing role of AI in MDS: digital twins, machine learning tools, and more
David Swoboda, MD, Tampa General Hospital Cancer Center, Tampa, FL, discusses the growing use of artificial intelligen...
ow.ly
#iwHRMM25 | Sham Mailankody of @MSKCancerCenter discusses innovative approaches to trial design in high-risk #myeloma, highlighting how these may improve data collection:
🎥
#Myeloma #MMSM #HemOnc #CTSM
Innovative approaches to trial design in high-risk myeloma & how these may improve data collection
Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the challenges of treating high...
ow.ly
🎥 @DrAEvens of @RutgersCancer shares insights into the HoLISTIC Consortium, a global NIH-funded initiative that has aggregated data from over 30,000 patients with #HodgkinLymphoma.
Learn more by clicking here:
👉 👈
#18ICML #LYMsm #Lymphoma #HemOnc
Insights into the HoLISTIC Consortium & the value of this initiative
Andrew Evens, DO, MBA, FACP, Rutgers University, New Brunswick, NJ, shares insights into the HoLISTIC Consortium, a ...
ow.ly
It was a pleasure to speak with the lovely @helgasimonm of @amsterdamumc at #iwCLL2025 to hear about her work investigating the metabolic fitness of T-cells in patients with CLL.🩸🔬
Click here to learn more:
👉 👈
#CLLsm #Leusm #Leukemia #ImmunoOnc…
Investigating the metabolic fitness of T-cells in patients with CLL
In this video, Helga Simon-Molas, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, discusses her work i...
ow.ly
We recently spoke with @aaronchengmd (@PennMedicine), who shared insights from an analysis of morbidity rates in adults with non-transfusion-dependent #thalassemia referred to three US specialty centers.
Watch the interview here:
👉 👈
#Hematology
Examining the morbidity rate in adults with NTDT referred to US specialty centers
Aaron Cheng, MD, University of Pennsylvania, Philadelphia, PA, discusses the high morbidity rate in adults with non-tr...
ow.ly
